Sailong Pharmaceutical Group Co., Ltd. (002898.SZ)
CNY 10.45
(-0.19%)
CNY 10.45
(-0.19%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 277.96 Million CNY | -13.58% |
| 2022 | 321.64 Million CNY | 0.79% |
| 2021 | 319.12 Million CNY | 40.61% |
| 2020 | 226.95 Million CNY | 28.26% |
| 2019 | 176.95 Million CNY | 91.71% |
| 2018 | 92.3 Million CNY | -4.35% |
| 2017 | 96.49 Million CNY | 88.43% |
| 2016 | 51.21 Million CNY | -0.63% |
| 2015 | 51.53 Million CNY | 5.32% |
| 2014 | 48.93 Million CNY | -34.27% |
| 2013 | 74.43 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 246.8 Million CNY | -11.21% |
| 2024 Q3 | 312.4 Million CNY | 20.33% |
| 2024 Q2 | 259.63 Million CNY | 5.2% |
| 2023 Q1 | 297.71 Million CNY | -7.44% |
| 2023 Q3 | 281.95 Million CNY | -14.0% |
| 2023 Q2 | 327.87 Million CNY | 10.13% |
| 2023 Q4 | 277.96 Million CNY | -1.42% |
| 2023 FY | 277.96 Million CNY | -13.58% |
| 2022 Q3 | 300.33 Million CNY | -2.34% |
| 2022 Q1 | 306.82 Million CNY | -3.85% |
| 2022 FY | 321.64 Million CNY | 0.79% |
| 2022 Q4 | 321.64 Million CNY | 7.09% |
| 2022 Q2 | 307.54 Million CNY | 0.23% |
| 2021 Q3 | 261.66 Million CNY | -2.27% |
| 2021 FY | 319.12 Million CNY | 40.61% |
| 2021 Q4 | 319.12 Million CNY | 21.96% |
| 2021 Q2 | 267.74 Million CNY | -3.52% |
| 2021 Q1 | 277.5 Million CNY | 22.27% |
| 2020 Q4 | 226.95 Million CNY | -12.51% |
| 2020 FY | 226.95 Million CNY | 28.26% |
| 2020 Q2 | 264.07 Million CNY | 37.07% |
| 2020 Q1 | 192.65 Million CNY | 8.87% |
| 2020 Q3 | 259.41 Million CNY | -1.77% |
| 2019 Q3 | 151.2 Million CNY | 15.2% |
| 2019 Q2 | 131.24 Million CNY | 144.31% |
| 2019 Q1 | 53.72 Million CNY | -41.8% |
| 2019 FY | 176.95 Million CNY | 91.71% |
| 2019 Q4 | 176.95 Million CNY | 17.03% |
| 2018 FY | 92.3 Million CNY | -4.35% |
| 2018 Q4 | 92.3 Million CNY | 9.68% |
| 2018 Q2 | 81.97 Million CNY | -18.09% |
| 2018 Q3 | 84.15 Million CNY | 2.66% |
| 2018 Q1 | 100.07 Million CNY | 3.71% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 FY | 96.49 Million CNY | 88.43% |
| 2017 Q4 | 96.49 Million CNY | 15.78% |
| 2017 Q3 | 83.34 Million CNY | 13.1% |
| 2017 Q2 | 73.68 Million CNY | 0.0% |
| 2016 FY | 51.21 Million CNY | -0.63% |
| 2016 Q4 | 51.21 Million CNY | 0.0% |
| 2015 FY | 51.53 Million CNY | 5.32% |
| 2014 FY | 48.93 Million CNY | -34.27% |
| 2013 FY | 74.43 Million CNY | 0.0% |